YH ENT (02306) · Company profile · Eqvero

YH ENT

02306HKEX

Unit: CNY	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	906.97 m CNY	764.54 m CNY	755.68 m CNY	980.25 m CNY	1.29 bn CNY
Cost of revenue	591.05 m CNY	519.51 m CNY	517.56 m CNY	561.21 m CNY	635.09 m CNY
Selling, general and administrative expense	189.2 m CNY	200.81 m CNY	214.92 m CNY	195.97 m CNY	172.95 m CNY
Operating profit after depreciation	78.72 m CNY	22.75 m CNY	17.55 m CNY	203.82 m CNY	463.51 m CNY
Operating profit before depreciation	120.72 m CNY	56.99 m CNY	33.21 m CNY	218.09 m CNY	477.13 m CNY
EBIT	78.72 m CNY	22.75 m CNY	17.55 m CNY	203.82 m CNY	463.51 m CNY
EBITDA	120.72 m CNY	56.99 m CNY	33.21 m CNY	218.09 m CNY	477.13 m CNY
Interest expense	2.99 m CNY	11.76 m CNY	4 m CNY	6.31 m CNY	42.75 m CNY
Profit before tax	96.05 m CNY	70.24 m CNY	-105.07 m CNY	1.79 bn CNY	461.04 m CNY
Income tax expense	24.21 m CNY	25.93 m CNY	37.52 m CNY	66.25 m CNY	125.71 m CNY
Income before extraordinary items	64.17 m CNY	46.94 m CNY	-140.84 m CNY	1.72 bn CNY	336.68 m CNY

Quotes are end-of-day data. Content is for research purposes and is not investment advice.